Search results for: patents

From poolside to patent office: keeping Olympians in the fast lane

Swimming has a rich history in the modern Olympics and, much like other sports, the level of performance has improved drastically since the inaugural games. In the Bay of Zea, Greece, in 1896, the win...

Emotional Perception: what today’s Court of Appeal decision means for AI patentability in the UK

The Court of Appeal has today dramatically overturned the Emotional Perception decision that was issued by the High Court in November. The Court of Appeal has decided that a trained artificial neural ...

Applying Emotional Perception at the UKIPO

On 2 January 2024, the UKIPO updated the Manual of Patent Practice (MoPP) to provide further guidance to patent examiners when examining patent applications involving artificial neural networks (ANNs)...

Turning lemons into lemonade: Professor Ryan Abbott on the patentability of AI inventions

In late 2023, the UK Supreme Court confirmed in its judgment that the UKIPO was correct to find that two patent applications designating an artificial intelligence (AI), known as DABUS, as the sole in...

UKIPO introduces updated guidelines for AI inventions

The UKIPO has recently published updated guidelines for the examination of patent applications that involve artificial intelligence (AI) inventions. These changes were driven by the UK Patent Court...

UPC/UP-DATE

The Unified Patent Court (UPC) has been fully operational for a year, and the Unitary Patent (UP), registerable at grant of a European patent, has been available for a year. To mark the occasion, we h...

Patent Law & Practice at a Glance

UK UPDATE Examining patent applications relating to artificial intelligence (AI) inventions The guidelines and scenarios explaining how the IPO examines AI inventions have been updated following the E...

RNA therapeutics: a glance at the patent filing landscape

RNA therapeutics have cemented their position as a cornerstone of modern medicine since their crucial role in alleviating the damage caused by the COVID-19 pandemic. The development of the mRNA vaccin...

C5’s 17th Annual Forum on Pharma & Biotech Patent Litigation in Europe | 29.05.2024

This event gathers leading experts and professionals from the pharmaceutical and biotechnology sectors to delve into the complex and ever-evolving landscape of patent litigation in Europe. Partner Ros...

A sign of the times: EPO relaxes rules for digital signatures on assignments and licences

On 1 April 2024, the EPO introduced new rules that relaxed the requirements for documents used to evidence assignments and licences....